A $1 million challenge, on behalf of the Centers for Disease Control and Prevention, to enhance testing for lead in children.
Phase 2 winners
Meridian Bioscience
First-place winner Meridian Bioscience is using electrochemical sensors to detect lead by measuring the electrical current in a blood sample.
OndaVia
Second-place winner OndaVia is applying optical technology to detect the presence of lead using a distinctive fingerprint signature.
GlucoSentient and UT Austin
Third-place winner GlucoSentient is adapting a blood glucose meter platform and using a DNAzyme sensor to detect lead in a blood sample.
About the challenge
The Lead Detect Prize seeks to accelerate the development of next-generation point-of-care blood lead testing technology. The challenge, on behalf of the Centers for Disease Control and Prevention, will advance blood lead test solutions by providing funding and expertise while fostering collaboration and partnership. Phase 1 awarded five winners an equal share of a $150,000 prize pool. Phase 1 winners were also exclusively invited to enter Phase 2 and participated in a virtual accelerator. Three Phase 2 winners were awarded a share of a $850,000 Phase 2 prize pool.
Timeline
In Phase 2, three winners were announced live at a Demo Day and awarded a share of $850,000.
Challenge launch
Phase 1 submission deadline
Phase 1 evaluation
Phase 1 winner announcement and Phase 2 start
Phase 2 submission period ends
Phase 2 Demo Day and winner announcement
PRIZE POOL
$1 million
The Lead Detect Prize awarded $1 million. Phase 1 awarded $150,000, and Phase 2 awarded a further $850,000.
Challenge resources
Access resources to learn more about the current issues in blood lead exposure testing and how to take a novel test from concept through regulatory approval and commercialization.